Searched for
AUROBINDO PHARMA FDA
Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...- Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
- Eugia Steriles' new injectables facility in Andhra receives its first product approval by FDAAurobindo Pharma Ltd announced that its subsidiary, Eugia Steriles Private Limited, received its first product approval from the US FDA for...
- Aurobindo's Andhra plant receives 1 observation from USFDA after inspectionAurobindo Pharma has received a Form 483 with one observation from the US FDA after an inspection of its formulation production facility in...
- Aurobindo Pharma tumbles 4%, hits 52-week low as USFDA issues 6 observationsFollowing the development, Aurobindo Pharma’s counter touched a 52-week low of Rs 581 on the BSE. The scrip had closed at Rs 603.05 on Tues...
- What's behind the flip-flop by USFDA on Aurobindo Pharma? Here's cueThere are similar examples to Aurobindo Pharma in the US where the approved ANDAs have been revoked by the USFDA because of certain pending...
- Aurobindo Pharma under USFDA scrutinyAurobindo has seen intense scrutiny on the manufacturer process of valsartan, an anti-hypertension drug, that was found to contain carcinog...
- Documents potentially misleading in Aurobindo Pharma's Unit-VII: USFDAThe FDA conducted a cGMP (Current Good Manufacturing Practices) inspection at the Unit 7 manufacturing facility from September 19-27 this y...
- Aurobindo Pharma drops 5% on USFDA observationsShares of Aurobindo Pharma declined to Rs 605.90.
- Buy Aurobindo Pharma, target Rs 909: Prabhudas LilladherBuy Aurobindo Pharma at a price target of Rs 909.
- Good news for Sun Pharma, bad news for Aurobindo: Amit Rajan, Prosfora Tech“India still has to do a lot of things, the FDA’s expectations are increasing day by day.”
- Aurobindo Pharma gets US FDA nod for Alzheimer's drug Memantine HydrochlorideAurobindo Pharma said it has received final approval from the US FDA to manufacture and market Memantine Hydrochloride used in treatment of...
- Aurobindo Pharma gets US FDA nod for generic osteoporosis drugAurobindo Pharma has received approval from the US FDA to manufacture and market its generic version of Eli Lilly's Evista tablets used to ...
- Aurobindo Pharma shares fall; company comes under USFDA lens, againShares of Aurobindo Pharma fell 4 per cent in intraday trade on Wednesday as the company again came under the USFDA lens.
- Aurobindo gets USFDA nod for chicken pox tabletsAurobindo Pharma said on Tuesday that it has received the nod from the US health regulator to manufacture and market its Valacyclovir Hydro...
- Ranbaxy, Aurobindo get US FDA nod for epilepsy drugPharma firm Ranbaxy on Monday said it has received US regulatory approval for Topiramate tablets, used in the treatment of epilepsy.
- Aurobindo Pharma gets USFDA nod for two drugsAurobindo Pharma on Friday said it has received approval from the US drug regulator for manufacturing and marketing two drugs - Cyclobenzap...
- Aurobindo receives US FDA nod for bacterial infection drugDrug maker Aurobindo Pharma said that it has received the US regulatory approval for its Cefazolin injection, used in the treatment of bact...
- Aurobindo gets FDA nod for marketing Alendronate tabletsDrug firm Aurobindo Pharma gets US regulatory approval to manufacture and market Alendronate Sodium tablets, used in the treatment of bone ...
- Aurobindo Pharma gets USFDA approval for CeftriaxoneDrug maker Aurobindo Pharma on Friday said it has recieved US regulatory approval for two drug applications in that country used in the tre...
Load More
